AI leaders call for tougher protections against AI-aided bioweapons
AI leaders urge Congress to mandate screening of synthetic DNA and RNA orders to reduce bioweapon risks.
Major AI rivals including leaders from Anthropic, OpenAI, Microsoft, Meta, and Google DeepMind signed an open letter urging US lawmakers to close a biosecurity gap. They want companies selling synthetic DNA and RNA to screen orders for sequences that could help create dangerous pathogens. The concern is that more capable AI tools and cheaper biology infrastructure could lower barriers to misuse.
The Verge reports that a number of leaders in the AI industry, who normally compete fiercely and often hold conflicting positions, this time stand on the same side over the issue of biosecurity. In an open letter to members of the US Congress, they call for legislation requiring companies that sell synthetic DNA and RNA to screen orders, in order to prevent gene sequences that could be used to create dangerous pathogens from being purchased, assembled, and used for improper purposes. Signatories include Anthropic's Dario Amodei, OpenAI's Sam Altman, Microsoft's Mustafa Suleyman, Meta AI head Alexandr Wang, and Google DeepMind's Demis Hassabis. The letter also won support from scientists, national-security and policy experts, and executives from synthetic genetic-material suppliers such as Twist Bioscience and Ansa Biotechnologies.
Free shows the 3-line summary; Pro unlocks the full deep summary (~300 words) so you never have to click through.
See Pro plans →Want the original English / full article?
Read on The Verge AI →Summaries are AI-generated; the original article is authoritative.